- pharmacology home
- personnel directory
- faculty research
- graduate training
- postdoctoral training
- professional courses
- research facilities
- seminars
The Department of Pharmaceutical and Biomedial Sciences joins the Department of Pharmacology to present the following seminars, held Tuesdays at 4:00 PM in QF-302A unless otherwise noted.
| DATE |
SPEAKER |
TITLE |
| August 28 |
Vincent Dammai, Ph.D. Assistant Professor Pathology and Laboratory Medicine MUSC |
Novel endocytic function of VHL in renal cancer. |
| September 4 |
Robert Schwabe Professor College of Physicians and Surgeons Columbia University |
Inflammatory signals in hepatic fibrogenesis. |
| September 11 |
Robert W. Sobol Jr., Ph.D. Assistant Professor Pharmacology Hillman Cancer Center University of Pittsburgh |
Base excision repair and chemotherapeutic response. |
| September 18 |
Dr. Mark Player Research Fellow and Team Leader Johnson and Johnson Pharmaceutical Research and Development |
Alpha-helix mimetics: inhibitors of the HDM2:p53 interaction. |
| September 25 |
Elizabeth Jonas, M.D. Assistant Professor Endocrinology Yale University |
Synaptic apopotosis: life and death of a synapse. |
| October 16 |
Jack Yalowich, Ph.D. Associate Professor Pharmacology University of Pittsburgh |
The paradox of anticancer drug-induced malignancies. |
| October 23 |
Anncatherine M. Downing, Pharm.D. Eli Lilly & Company |
Pharmacogenomics: an industry perspective. |
| October 30 |
Ian Blair, Ph.D. Professor Pharmacology University of Pennsylvania |
Cyclooxygenase-2-mediated lipid peroxidation: discovery of a new family of eicosanoids. |
| November 6 |
David A. Colby, Ph.D. Department of Chemistry The Scripps Research Institute Faculty Candidate |
Natural products as lead structures for medicinal chemistry. |
| November 13 |
Ryan Fiorini, Ph.D. Licensing and Technology Analyst Foundation for Research Development, MUSC |
Licensing technology. |
| November 20 12 noon QF-302B |
Matthew B. Soellner, Ph.D. Department of Chemistry University of California, Berkeley Faculty Candidate |
Addressing biological problems using organic chemistry. |
| November 20 4 pm QF-302A |
Jessie L.-S. Au, Pharm.D., Ph.D. Distinguished University Professor Ohio State University |
Pharmaceutical and translational sciences: a multidisciplinary platform for cancer therapy development. |
| November 27 |
Joseph Bonventre, M.D., Ph.D. Professor Medicine and Health Sciences and Technology Harvard University |
Cell injury and repair. |
| Wednesday November 28 4-5PM |
Kenyon G. Daniel, Ph.D. Moffitt Cancer Center and Research Institute Faculty Candidate |
Bridging the gap: combining the disciplines of biochemistry and computational modeling. |
| December 4 |
David Miller, Ph.D. NIEHS/NIH |
Controlling p-glycoprotein, an 800-lb gorilla that limits drug access to the CNS. |
| Thursday December 6 12-1PM QF-302B |
Bin Su, Ph.D. City of Hope National Medical Center Faculty Candidate |
After SERMS and aromatase inhibitors: what could be next for hormone dependent breast cancer? |
| December 11 |
Keykavous Parang, Pharm.D.,
Ph.D. Department of Biomedical and Pharmaceutical Sciences University of Rhode Island Faculty Candidate |